App-Based Certified Diabetes Education Therapy (AB-CDE)
NCT: NCT07282639 · RECRUITING
Brief Summary
The purpose of this study is to learn more about a smartphone application (app) called DailyDose, an investigational decision support tool that may help in managing your diabetes. DailyDose tracks your continuous glucose monitoring (CGM) data, insulin use, and exercise, and uses this information to provide personalized recommendations for insulin dosing and carbohydrate intake during exercise or low blood sugar events. We want to find out if DailyDose can help lower blood sugar levels as measured by the hemoglobin A1c (HbA1c) test.
Frequently Asked Questions
What is App-Based Certified Diabetes Education Therapy (AB-CDE)?
App-Based Certified Diabetes Education Therapy (AB-CDE) is a clinical trial registered under NCT07282639. Current status: RECRUITING.
What is the status of NCT07282639?
The current status of NCT07282639 (App-Based Certified Diabetes Education Therapy (AB-CDE)) is: RECRUITING.
When did App-Based Certified Diabetes Education Therapy (AB-CDE) start?
App-Based Certified Diabetes Education Therapy (AB-CDE) started on 2026-07-08.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.